Artificial Intelligence is rapidly transforming the life sciences industry. But how can organisations harness its potential while maintaining the quality, compliance and control expected within a regulated GxP environment?
This will be a key focus of KENX’s Harness the Power of AI in GxP – Singapore 2026, taking place on 19–20 November 2026, with SeerPharma proudly participating as a Gold Sponsor.
KENX is a global knowledge and events organisation with more than three decades of experience supporting the life sciences industry. With its roots in the FDA and global GxP environment, KENX brings together industry experts, regulatory authorities and practitioners to share knowledge, exchange experience and explore emerging challenges across the sector.
AI is creating significant opportunities across life sciences, from improving efficiency and decision-making to strengthening quality and optimising GxP processes. However, its adoption also brings challenges around governance, validation, data integrity, risk management, cybersecurity and regulatory compliance.
KENX’s two-day conference in Singapore, will bring together leading professionals from across the pharmaceutical, biotechnology and life sciences sectors to explore the practical application of AI in regulated environments.
Key topics will include:
-
Regulatory expectations and emerging AI frameworks
-
AI validation and assurance
-
AI-enabled automation within GMP
-
Data integrity, quality and risk management
-
Predictive analytics and process improvement
-
AI applications across manufacturing and supply chain
-
AI governance, transparency and accountability
SeerPharma is proud to be a Gold Sponsor of KENX’s Harness the Power of AI in GxP – Singapore 2026.
As AI moves from experimentation into increasingly important GxP applications, organisations need more than technological capability. They need effective governance, appropriate validation, clear accountability and ongoing oversight.
As part of the conference program, SeerPharma Director Ian Lucas will lead a session on A Holistic Governance Framework for AI in GxP.
Ian will explore how organisations can establish a practical, integrated framework for responsible AI adoption, addressing quality, regulatory compliance, risk management, data governance, validation, and ongoing monitoring.
Effective AI governance requires more than an IT-led approach. It requires collaboration across Quality, Regulatory, IT, Data, Risk, Compliance and business leadership.
Whether you are exploring your first AI use cases, progressing existing initiatives or developing an enterprise-wide AI governance framework, KENX Singapore 2026 provides an opportunity to hear from leading authorities working at the forefront of AI and GxP.
Join SeerPharma in Singapore on 19–20 November 2026 as we explore how the life sciences industry can harness the power of AI — responsibly, effectively and compliantly.
Use our code SEER200 for $200 off registration.
Learn more and register for this leading event.
We look forward to seeing you there.
